A. Bryant

发表

A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemia

H. Atkins, D. Allan, B. Zanke, 2015, Leukemia & lymphoma.

Expression profiling of cytogenetically normal acute myeloid leukemia identifies MicroRNAs that target genes involved in monocytic differentiation

Vivek Jayaswal, Y. H. Yang, M. Lutherborrow, 2011, American journal of hematology.

Timely diagnosis and management of heparin‐induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T’s score and particle gel immunoassay

J. Low, S. Austin, J. Joseph, 2008, British journal of haematology.

Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation.

H. Atkins, D. Allan, L. Huebsch, 2016, JAMA neurology.

Pre-salvage ISS and Other Important Outcome Associations in CD34 Selected Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma.

M. Perales, O. Landgren, S. Giralt, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Severe pembrolizumab-associated neutropenia after CD34+ selected allogeneic hematopoietic-cell transplantation for multiple myeloma

M. Perales, J. Peled, S. Giralt, 2018, Bone Marrow Transplantation.

Advances in ex vivo T cell depletion – where do we stand?

M. Perales, A. Bryant, 2018, Advances in cell and gene therapy.

Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients

B. George, G. Kennedy, A. Bryant, 2014, Bone Marrow Transplantation.

Prognostic Factors for Post-Relapse Survival after ex-vivo CD34+-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma.

M. Perales, R. Baser, Arnab Ghosh, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease.

J. Storek, P. Duggan, V. Jimenez-Zepeda, 2022, Cytotherapy.

The clinicopathological relevance of microRNA in normal and malignant haematopoiesis

M. Lutherborrow, David Ma, A. Bryant, 2009, Pathology.

miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death

Vivek Jayaswal, M. Lutherborrow, David D. F. Ma, 2012, Molecular Cancer.

Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling

Anna Campain, Y. H. Yang, M. Lutherborrow, 2011, BMC Medical Genomics.

Thymic Immunophenotype, and Expression of CD4 and Myeloid Antigens isAssociated with Outcome in Adult Patients with TÃ¢ÂÂCell Acute LymphoblasticLeukemia

A. Bryant, J. Pal, Y. A. Mourad, 2015 .

IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers.

D. Cooper, A. Kelleher, M. Munier, 2010, Cytokine.

Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulation

L. Huebsch, S. Mcdiarmid, C. Bredeson, 2013, Bone Marrow Transplantation.

Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.

H. Atkins, D. Allan, L. Huebsch, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

I. Kerridge, D. Ma, W. Stevenson, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful reduced-intensity conditioning allogeneic HSCT for HIV-related primary effusion lymphoma.

A. Bryant, S. Milliken, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of Donor Age and Donor Relatedness on Time to Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia.

H. Atkins, D. Allan, L. Huebsch, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Does Lymphocyte Count Impact Dosing of Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplantation?

H. Atkins, D. Allan, L. Huebsch, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Aberrant expression of CD13 identifies a subgroup of standard-risk adult acute lymphoblastic leukemia with inferior survival.

A. Bryant, J. Pal, S. Lau, 2014, Clinical lymphoma, myeloma & leukemia.

MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia

Vivek Jayaswal, David D. F. Ma, A. Bryant, 2014, Molecular Cancer.

Rituximab and its potential for the treatment of rheumatoid arthritis

J. Moore, A. Bryant, 2006, Therapeutics and clinical risk management.

Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma

V. Choeurng, T. Plesner, A. Vangsted, 2023, Clinical Hematology International.

Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study

I. Kerridge, C. Tiley, S. Harrison, 2020 .

Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres

S. Ling, J. Moore, A. Bryant, 2020, Bone Marrow Transplantation.

A Phase I Study of RO7297089, a B-Cell Maturation Antigen (BCMA)-CD16a Bispecific Antibody in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

V. Choeurng, T. Plesner, A. Vangsted, 2021, Blood.

IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers.

D. Cooper, A. Kelleher, M. Munier, 2010, Cytokine.